Queens personalized care and ongoing monitoring, youll have expert guidance every step of the way, ensuring your progress is safe, effective, and tailored to your needs
In recent years, studies on the use of GLP-1R and GLP-1R agonists to reduce tau protein hyperphosphorylation have progressed
While these medications primarily reduce fat body mass (FBM), loss of lean body mass (LBM) can also occur, raising concerns about muscle loss in susceptible populations, such as frail individuals and older adults
Who Classification of Skin Tumours, 4th Edition
*Correspondence: Rong Li, [email protected] This article was submitted to Pharmacoepidemiology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers